![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Barrios, Carlos H.; Saji, Shigehira; Harbeck, Nadia; Zhang, Hong; Jung, Kyung H.; Patel, Sheetal; Patel, Shilpen; Anh Nguyen, Duc; Liste-Hermoso, Mario; Chui, Stephen Y. und Mittendorf, Elizabeth A.
(2022):
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer.
In: Npj Breast Cancer, Bd. 8, Nr. 1, 108
2020
Mittendorf, Elizabeth A.; Zhang, Hong; Barrios, Carlos H.; Saji, Shigehira; Jung, Kyung Hae; Hegg, Roberto; Koehler, Andreas; Sohn, Joohyuk; Iwata, Hiroji; Telli, Melinda L.; Ferrario, Cristiano; Punie, Kevin; Penault-Llorca, Frederique; Patel, Shilpen; Anh Nguyen, Duc; Liste-Hermoso, Mario; Maiya, Vidya; Molinero, Luciana; Chui, Stephen Y. und Harbeck, Nadia
(2020):
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
In: Lancet, Bd. 396, Nr. 10257: S. 1090-1100
Cortes, Javier; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Curigliano, Giuseppe; El Saghir, Nagi S.; Cardoso, Fatima; Barrios, Carlos H.; Wagle, Shama; Roman, Javier; Harbeck, Nadia; Eniu, Alexandru; Kaufman, Peter A.; Tabernero, Josep; Garcia-Estevez, Laura; Schmid, Peter und Arribas, Joaquin
(2020):
Enhancing global access to cancer medicines.
In: CA : A Cancer Journal for Clinicians, Bd. 70, Nr. 2: S. 105-124
2019
Montemurro, Filippo; Ellis, Paul; Anton, Antonio; Wuerstlein, Rachel; Delaloge, Suzette; Bonneterre, Jacques; Quenel-Tueux, Nathalie; Linn, Sabine C.; Irahara, Natsumi; Donica, Margarita; Lindegger, Nicolas und Barrios, Carlos H.
(2019):
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1.
In: European Journal of Cancer, Bd. 109: S. 92-102